Publications by authors named "Shikai Lin"
Article Synopsis
- PARP inhibitors (PARPi) are a type of anticancer drug that target cancer cells lacking effective DNA repair mechanisms, known as homologous recombination repair deficiency (HRD).
- Four main PARPi, Olaparib, Rucaparib, Niraparib, and Talazoparib, have been approved and shown to improve outcomes for patients with specific cancers like ovarian, breast, pancreatic, and prostate.
- Despite their effectiveness, some patients develop resistance to PARPi, prompting discussions on the underlying mechanisms of this resistance and potential strategies to counteract it.
According to the serious problem of sulfur dioxide pollution, montmorillonite is one of the effective ways in gas pollution control because of its excellent absorption properties. One of the fundamental questions is to fully understand sulfur dioxide absorption mechanism of montmorillonite. In this study, using the first-principle methods, we studied the adsorption characteristics of Ca-montmorillonite in the presence of [Formula: see text].
View Article and Find Full Text PDF